Skip to content

Automatic Urine Analyzer

by Shandong Bohong Gene Technology Co., Ltd. 2 variants

Ref BH-QNY02Model BH-QNY series

Automatic Urine Analyzer (BH-QNY02) is an in vitro diagnostic device (EU IVDR Class A; EMDN category automated urine analysers) made by Shandong Bohong Gene Technology Co., Ltd., registered in EUDAMED on 25 May 2026 (Basic UDI-DI 69749019723QNY**J2), active as of 24 Oct 2026.

Active European Union

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, synced 24 Oct 2026.

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number69749019723QNY**J2 Basic UDI-DI 06974901972367UDI-DIDate25 May 2026RegisteredStatusActive

Official records

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDR Active

Specification

EUDAMED

Model / reference
BH-QNY series, BH-QNY02
Primary DI / UDI-DI
06974901972367
Basic UDI-DI
69749019723QNY**J2
EMDN code
W020101020103 Automated urine analysers
Device class
Class A
EU registration type
Standard device
EU market of registration
Germany

Manufacturer details

EUDAMED SRN
CN-MF-000025971
Authorised representative
Luxus Lebenswelt GmbH DE-AR-000005110

Similar devices in this category

Other devices filed under AUTOMATED URINE ANALYSERS.

Other devices from Shandong Bohong Gene Technology Co., Ltd.

See all devices from Shandong Bohong Gene Technology Co., Ltd. →

Properties

  • Professional testing
  • IVD instrument
Other properties (11, all answered No)